Author:
Chancellor Michael B.,Yehoshua Alon,Waweru Catherine,Globe Denise,Cheng I-Ning,Campbell Karen L.,Joshi Manher,Pulicharam Riya
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Haylen BT, de Ridder D, Freeman RM et al (2010) International Urogynecological Association; International Continence Society. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 29:4–20
2. Stewart WF, Van Rooyan JB, Cundiff GW et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336
3. Litwin MS, Saigal CS (eds) (2012) Urologic diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. US Government Printing Office, Washington, DC NIH Publication No. 12-7865
4. D’Souza AO, Smith MJ, Miller LA, Doyle J, Ariely R (2008) Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan. J Manag Care Pharm 14:291–301
5. Gopal M, Haynes K, Bellamy SL, Arya LA (2008) Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms. Obstet Gynecol 112:1311–1318
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献